Unknown OBSERVATIONAL NCT02750852

An Algorithm for Predicting Blood Loss and Transfusion Risk in Fast Track Total Hip Arthroplasty

Sponsor: Azienda Ospedaliera Bolognini di Seriate Bergamo

Conditions Blood Loss Total Hip Replacement

Interventions Total hip arthroplasty, blood loss analysis

Updated 6 times since 2017 Last updated: Apr 21, 2016 Started: Apr 30, 2016 Primary completion: Apr 30, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02750852, this observational or N/A phase trial focuses on Blood Loss and Total Hip Replacement and remains ongoing. Sponsored by Azienda Ospedaliera Bolognini di Seriate Bergamo, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
May 2018 — Jan 2021 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Apr 2018 — May 2018 [monthly]

Active Not Recruiting

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera Bolognini di Seriate Bergamo

Data source: Azienda Ospedaliera Bolognini di Seriate Bergamo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.